AIP
PPH icon

Almanack Investment Partners’s VanEck Pharmaceutical ETF PPH Stock Holding History

Almanack Investment Partners’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,771
Closed -$239K – 183
2024
Q4 		$239K Hold
2,771
– – 0.04% 159
2024
Q3 		$263K Hold
2,771
– – 0.04% 156
2024
Q2 		$253K Hold
2,771
– – 0.04% 156
2024
Q1 		$251K Hold
2,771
– – 0.04% 156
2023
Q4 		$225K Buy
+2,771
New +$217K 0.04% 147
2022
Q1 		– Sell
-2,782
Closed -$214K – 520
2021
Q4 		$214K Buy
+2,782
New +$207K 0.02% 454

Other funds holding PPH

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Almanack Investment Partners's PPH Position: Q1 2025 in Review

Almanack Investment Partners sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2025, closing a stake of 2,771 shares — an estimated $239K sold.

Almanack Investment Partners first reported a position in PPH in Q4 2021 and held it in 6 quarters. The position peaked at $263K in Q3 2024. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.

  • Almanack Investment Partners reported no remaining VanEck Pharmaceutical ETF position as of Q1 2025 after selling out during the quarter.
  • Almanack Investment Partners sold 2,771 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $239K.
  • Almanack Investment Partners first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and held it in 6 quarters.
  • Almanack Investment Partners's VanEck Pharmaceutical ETF position peaked at $263K in Q3 2024.
  • 136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.

Based on Almanack Investment Partners's 13F filing for Q1 2025, filed 25 Apr 2025.